Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 590 across all filing types
Latest filing 2017-12-08 Regulatory Filings
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
RaySearch släpper RayStation 7, med inkluderat stöd för integration med RayCare och Mevion Hyperscan
Regulatory Filings Classification · 95% confidence The document is a press release dated December 8, 2017, announcing the launch of a new software product, 'RayStation 7', and mentioning the upcoming launch of another product, 'RayCare'. It details new features, technological integrations (like Mevion Hyperscan), and strategic goals. This type of announcement, detailing a new product release or significant update, is generally classified as a general business or product announcement. Since it is not a formal regulatory filing (like 10-K, AR, or ER), nor is it specifically about management changes (MANG), dividends (DIV), or financing (CAP), it fits best under the general regulatory/news announcement category, which is RNS (Regulatory Filings) as the fallback for miscellaneous announcements that don't fit specific financial reporting codes. Given the document length (4431 chars) and content (a detailed product launch announcement), it is not a simple RPA (Report Publication Announcement).
2017-12-08 Swedish
Raystation footprint increases in Southern California
Regulatory Filings Classification · 95% confidence The document is titled "PRESS RELEASE" and announces a specific business event: a hospital selecting RayStation as its treatment planning system. This is a corporate announcement regarding business development and sales, not a mandatory regulatory filing like a 10-K, an earnings release (ER), or a formal capital/financing update (CAP). It does not fit the definitions for AGM-R, AR, MANG, CT, DVA, DLST, DIRS, SR, XLSX, FS, CGR, IRAT, IR, IP, LTR, TAR, MRQ, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. Since it is a general, non-mandatory business update that doesn't fit the highly specific categories, the most appropriate fallback classification is Regulatory Filings (RNS), which serves as the general category for miscellaneous announcements.
2017-12-07 English
RayStation ökar sin närvaro i södra Kalifornien
Regulatory Filings Classification · 93% confidence The document is a press release dated December 7, 2017, announcing that Sharp Grossmont Hospital has selected RayStation as its primary dose planning system. This is a commercial announcement detailing a customer win and product adoption, not a mandatory regulatory filing like a 10-K, an earnings release (ER), or a formal capital/financing update (CAP). It does not fit the definitions for AGM-R, AR, MANG, CT, DVA, DLST, DIRS, SR, XLSX, FS, CGR, IRAT, IR, IP, LTR, TAR, MRQ, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. Since it is a specific business announcement that doesn't fit the primary categories, the most appropriate fallback category is Regulatory Filings (RNS), as it serves as a general corporate announcement, although 'RPA' (Report Publication Announcement) is sometimes used for press releases, RNS is the designated general regulatory/announcement fallback.
2017-12-07 Swedish
Major Shareholding Notification 2017
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding for Lannebo Fonder AB concerning RaySearch Laboratories AB (publ). Specifically, it shows the 'Before the transaction' and 'After the transaction' share quantities and the resulting percentage of voting rights, noting the 'Reason for major shareholding notification Sell'. This structure is characteristic of a notification regarding a significant change in ownership, which aligns directly with the definition of Major Shareholding Notification (MRQ). The document is a formal report of this change, not an announcement of a report (RPA) or a general regulatory filing (RNS).
2017-11-24 English
Earnings Release 2017
Earnings Release Classification · 99% confidence The document contains detailed financial tables showing performance metrics for specific periods (JUL-SEP, JAN-SEP, OKT 2016-SEP 2017) including Nettoomsättning (Net Sales), Rörelseresultat (Operating Result), Resultat per aktie (Earnings per share), and Cash Flow. It also includes a detailed commentary from the CEO ('VD:S KOMMENTAR') discussing business strategy, product performance (RayStation, RayCare), market expansion, and financial results for the first nine months of 2017. The structure, detailed financial breakdowns by period, and management discussion are characteristic of a comprehensive periodic financial report, specifically an Interim/Quarterly Report, rather than just a brief earnings release (ER) or a simple announcement (RPA/RNS). Since it covers the first nine months ('Under årets nio första månader'), it aligns perfectly with the definition of an Interim/Quarterly Report (IR). 9M 2017
2017-11-22 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first nine months of 2017 (Jan-Sep). It contains detailed financial tables (Net sales, Operating profit, Cash flow, etc.), CEO commentary, and analysis of business performance. It is not an announcement of a report (RPA) or a simple earnings release (ER), as it provides substantive financial data and analysis for an interim period. Therefore, it is classified as an Interim/Quarterly Report. 9M 2017
2017-11-22 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.